Deutsche Bank Initiates PTC Therapeutics At Buy By: Benzinga via Benzinga September 15, 2014 at 07:39 AM EDT Analysts at Deutsche Bank initiated coverage on shares of PTC Therapeutics (NASDAQ: PTCT) with a Buy rating. The target price for ... Read More >> Related Stocks: Ptc Therapeutics